CDKN2A and cancer: Interestingly, knockdown of RBM4 still induced senescence in cancer cells bearing mutations or deletions of P53, P16 (INK4A), and K-Ras (Fig. 2h), suggesting that depleted RBM4 might activate senescence via P27 pathway.